Free Trial
→ The Iran War Just Broke the Gold Market (From Behind the Markets) (Ad)tc pixel Free BTSGU Stock Alerts

BrightSpring Health Services (BTSGU) Financials

BrightSpring Health Services logo
$192.20 +5.79 (+3.10%)
Closing price 05/15/2026 03:58 PM Eastern
Extended Trading
$191.44 -0.76 (-0.40%)
As of 05/15/2026 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for BrightSpring Health Services

Annual Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -54 -155 -18 191
Consolidated Net Income / (Loss)		 -54 -157 -21 189
Net Income / (Loss) Continuing Operations		 -54 -182 -69 105
Total Pre-Tax Income 		-46 -214 -95 138
Total Operating Income		 188 58 108 295
Total Gross Profit		 1,354 1,139 1,266 1,518
Total Revenue		 7,721 7,691 10,072 12,911
Operating Revenue		 7,721 7,691 10,072 12,911
Total Cost of Revenue		 6,366 6,552 8,806 11,393
Operating Cost of Revenue		 6,366 6,552 8,806 11,393
Total Operating Expenses		 1,166 1,081 1,158 1,223
Selling, General & Admin Expense		 1,126 1,081 1,158 1,223
Total Other Income / (Expense), net		 -234 -272 -203 -157
Interest Expense		 234 272 203 157
Income Tax Expense		 8.47 -32 -26 33
Net Income / (Loss) Discontinued Operations		 - 25 48 84
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.31 -2.23 -2.46 -1.55
Basic Earnings per Share		 ($0.46) ($1.31) ($0.09) $0.94
Weighted Average Basic Shares Outstanding		 117.84M 117.87M 193.00M 202.56M
Diluted Earnings per Share		 ($0.46) ($1.31) ($0.09) $0.87
Weighted Average Diluted Shares Outstanding		 117.84M 117.87M 193.00M 219.77M
Weighted Average Basic & Diluted Shares Outstanding		 - - 174.97M 193.54M

Quarterly Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -131 -6.54 -46 20 -8.23 16 30 28 56 77 149
Consolidated Net Income / (Loss)		 -130 -7.20 -46 19 -8.98 15 29 28 55 77 149
Net Income / (Loss) Continuing Operations		 -130 -7.20 -56 8.49 -26 15 9.22 8.54 37 50 74
Total Pre-Tax Income 		-136 -15 -83 -4.63 -18 24 8.98 9.78 50 70 83
Total Operating Income		 -52 68 -15 39 29 79 51 49 88 108 121
Total Gross Profit		 358 369 292 312 323 422 338 375 392 413 482
Total Revenue		 2,257 2,375 2,286 2,438 2,601 3,053 2,878 3,148 3,334 3,551 3,614
Operating Revenue		 2,257 2,375 2,286 2,438 2,601 3,053 2,878 3,148 3,334 3,551 3,614
Total Cost of Revenue		 1,898 2,006 1,993 2,126 2,278 2,631 2,540 2,773 2,942 3,138 3,131
Operating Cost of Revenue		 1,898 2,006 1,993 2,126 2,278 2,631 2,540 2,773 2,942 3,138 3,131
Total Operating Expenses		 411 300 308 274 294 343 288 326 304 304 361
Selling, General & Admin Expense		 411 300 308 274 294 343 288 326 304 304 361
Total Other Income / (Expense), net		 -84 -83 -67 -43 -47 -55 -42 -39 -38 -39 -39
Interest Expense		 84 83 67 43 47 55 42 39 38 39 39
Income Tax Expense		 -5.81 -7.59 -27 -13 8.16 8.78 -0.24 1.24 12 20 8.55
Net Income / (Loss) Discontinued Operations		 - - 9.64 11 17 - 20 19 18 28 74
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.55 -0.66 -0.64 -0.48 -0.75 -0.60 -0.53 -0.67 -0.60 0.24 -0.16
Basic Earnings per Share		 ($1.11) ($0.05) ($0.26) $0.10 ($0.04) $0.11 $0.15 $0.14 $0.27 $0.38 $0.73
Weighted Average Basic Shares Outstanding		 117.86M 117.87M 175.53M 197.52M 198.49M 193.00M 201.01M 201.81M 203.49M 202.56M 204.71M
Diluted Earnings per Share		 ($1.11) ($0.05) ($0.26) $0.10 ($0.04) $0.11 $0.14 $0.13 $0.26 $0.34 $0.67
Weighted Average Diluted Shares Outstanding		 117.86M 117.87M 175.53M 208.99M 198.49M 193.00M 214.93M 216.34M 217.98M 219.77M 221.32M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 171.32M 171.46M 174.13M 174.97M 174.25M 177.15M 180.35M 193.54M 193.92M

Annual Cash Flow Statements for BrightSpring Health Services

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -33 -0.56 48 27
Net Cash From Operating Activities		 -4.65 211 24 490
Net Cash From Continuing Operating Activities		 -4.65 211 24 490
Net Income / (Loss) Continuing Operations		 -54 -157 -21 189
Consolidated Net Income / (Loss)		 -54 -157 -21 189
Depreciation Expense		 204 202 204 164
Amortization Expense		 20 21 12 11
Non-Cash Adjustments To Reconcile Net Income		 78 38 124 129
Changes in Operating Assets and Liabilities, net		 -252 107 -296 -3.70
Net Cash From Investing Activities		 45 -134 -140 -305
Net Cash From Continuing Investing Activities		 45 -134 -140 -305
Purchase of Property, Plant & Equipment		 -70 -74 -81 -95
Acquisitions		 -42 -63 -60 -205
Other Investing Activities, net		 2.14 2.15 0.47 -5.03
Net Cash From Financing Activities		 -74 -77 165 -158
Net Cash From Continuing Financing Activities		 -74 -77 165 -158
Repayment of Debt		 -41 -30 -3,443 -50
Repurchase of Preferred Equity		 0.00 -10 0.00 0.00
Repurchase of Common Equity		 0.00 -0.65 -2.97 -48
Issuance of Debt		 -17 -24 2,968 -63
Issuance of Common Equity		 0.23 1.33 658 25
Other Financing Activities, net		 -15 -13 -15 -21
Cash Interest Paid		 213 304 211 184
Cash Income Taxes Paid		 29 37 25 27

Quarterly Cash Flow Statements for BrightSpring Health Services

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.39 1.43 45 -33 11 25 -8.61 18 71 -53 800
Net Cash From Operating Activities		 34 162 -79 -15 27 91 102 49 108 232 123
Net Cash From Continuing Operating Activities		 34 162 -79 -15 27 91 102 49 108 232 123
Net Income / (Loss) Continuing Operations		 -130 -7.20 -46 19 -8.98 15 29 28 55 77 149
Consolidated Net Income / (Loss)		 -130 -7.20 -46 19 -8.98 15 29 28 55 77 149
Depreciation Expense		 51 51 49 50 51 55 42 42 41 40 39
Amortization Expense		 5.18 5.23 4.45 2.49 2.54 2.63 2.75 2.79 2.84 2.86 2.82
Non-Cash Adjustments To Reconcile Net Income		 9.62 7.49 46 21 27 30 28 55 20 26 -96
Changes in Operating Assets and Liabilities, net		 98 106 -132 -108 -44 -12 -0.72 -78 -11 86 29
Net Cash From Investing Activities		 -55 -17 -31 -58 -36 -16 -24 -23 -24 -234 747
Net Cash From Continuing Investing Activities		 -55 -17 -31 -58 -36 -16 -24 -23 -24 -234 747
Purchase of Property, Plant & Equipment		 -18 -17 -22 -24 -20 -15 -18 -24 -16 -38 -22
Acquisitions		 -37 -0.55 -9.39 -34 -16 -0.04 -6.75 - -1.55 -196 -42
Divestitures		 - - - - - - 0.00 - - - 811
Other Investing Activities, net		 0.30 0.36 0.27 0.27 0.36 -0.43 0.20 1.18 -6.45 0.04 0.23
Net Cash From Financing Activities		 21 -144 155 40 20 -50 -86 -8.24 -13 -50 -70
Net Cash From Continuing Financing Activities		 21 -144 155 40 20 -50 -86 -8.24 -13 -50 -70
Repayment of Debt		 -7.54 -7.58 -3,453 -2,527 -14 -16 -12 -12 -14 51 -12
Repurchase of Common Equity		 -0.33 -0.33 -0.63 -0.33 -2.02 - -5.10 - - -43 -60
Issuance of Debt		 32 -122 2,955 2,571 41 -34 -63 - - -63 0.00
Issuance of Common Equity		 0.45 0.74 656 0.40 0.13 1.00 0.35 8.72 5.62 11 12
Other Financing Activities, net		 -2.90 -4.42 -3.08 -4.13 -6.22 -1.20 -6.17 -5.03 -4.51 -5.58 -9.76
Cash Interest Paid		 78 78 60 51 54 46 54 42 42 46 43
Cash Income Taxes Paid		 9.08 1.86 11 13 0.62 0.64 0.25 13 1.83 12 0.40

Annual Balance Sheets for BrightSpring Health Services

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 5,533 5,926 6,413
Total Current Assets		 1,457 1,893 2,894
Cash & Equivalents		 13 61 88
Accounts Receivable		 882 903 990
Inventories, net		 403 637 815
Prepaid Expenses		 159 161 119
Other Current Nonoperating Assets		 - 131 882
Plant, Property, & Equipment, net		 246 181 205
Total Noncurrent Assets		 3,830 3,853 3,315
Goodwill		 2,608 2,364 2,546
Intangible Assets		 881 595 558
Noncurrent Deferred & Refundable Income Taxes		 0.00 5.29 0.00
Other Noncurrent Operating Assets		 340 200 211
Other Noncurrent Nonoperating Assets		 - 688 0.00
Total Liabilities & Shareholders' Equity		 5,533 5,926 6,413
Total Liabilities		 4,920 4,275 4,527
Total Current Liabilities		 1,248 1,428 1,849
Short-Term Debt		 32 49 52
Accounts Payable		 642 924 1,218
Accrued Expenses		 492 296 333
Other Current Liabilities		 82 42 50
Other Current Nonoperating Liabilities		 - 118 196
Total Noncurrent Liabilities		 3,672 2,846 2,678
Long-Term Debt		 3,332 2,562 2,455
Capital Lease Obligations		 224 136 15
Noncurrent Deferred & Payable Income Tax Liabilities		 24 0.00 6.18
Other Noncurrent Operating Liabilities		 92 71 202
Other Noncurrent Nonoperating Liabilities		 - 77 0.00
Redeemable Noncontrolling Interest		 27 3.73 11
Total Equity & Noncontrolling Interests		 585 1,648 1,875
Total Preferred & Common Equity		 585 1,648 1,875
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 585 1,648 1,875
Common Stock		 773 1,869 1,956
Retained Earnings		 -200 -222 -75
Accumulated Other Comprehensive Income / (Loss)		 13 1.42 -6.69
Noncontrolling Interest		 0.67 0.00 0.07

Quarterly Balance Sheets for BrightSpring Health Services

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 5,656 5,605 5,786 5,847 5,944 6,049 6,213
Total Current Assets		 1,573 1,522 1,710 2,528 2,648 2,780 2,689
Cash & Equivalents		 58 25 36 52 70 140 889
Accounts Receivable		 991 985 1,026 975 973 1,013 1,114
Inventories, net		 374 374 478 534 625 639 560
Prepaid Expenses		 150 138 170 131 129 124 127
Other Current Nonoperating Assets		 - - - 836 850 864 0.00
Plant, Property, & Equipment, net		 246 246 249 177 178 175 202
Total Noncurrent Assets		 3,837 3,838 3,828 3,141 3,118 3,094 3,322
Goodwill		 2,609 2,626 2,673 2,370 2,370 2,371 2,534
Intangible Assets		 856 851 842 568 544 522 537
Noncurrent Deferred & Refundable Income Taxes		 11 22 6.68 2.31 3.33 0.00 0.00
Other Noncurrent Operating Assets		 361 338 306 201 200 202 252
Other Noncurrent Nonoperating Assets		 - - - 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 5,656 5,605 5,786 5,847 5,944 6,049 6,213
Total Liabilities		 4,081 3,999 4,167 4,156 4,198 4,228 4,223
Total Current Liabilities		 1,245 1,145 1,264 1,458 1,505 1,550 1,548
Short-Term Debt		 49 49 49 49 51 52 53
Accounts Payable		 656 669 784 868 965 954 1,091
Accrued Expenses		 452 347 349 303 253 304 352
Other Current Liabilities		 89 80 82 42 42 43 52
Other Current Nonoperating Liabilities		 - - - 196 194 197 0.00
Total Noncurrent Liabilities		 2,836 2,854 2,903 2,699 2,693 2,679 2,675
Long-Term Debt		 2,515 2,564 2,609 2,489 2,478 2,465 2,445
Capital Lease Obligations		 24 220 221 137 141 139 150
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 0.00 0.00 0.00 0.00 10 1.17
Other Noncurrent Operating Liabilities		 297 71 74 73 74 64 79
Other Noncurrent Nonoperating Liabilities		 - - - 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 6.28 5.94 4.13 3.32 2.82 2.36 11
Total Equity & Noncontrolling Interests		 1,568 1,600 1,615 1,687 1,743 1,819 1,979
Total Preferred & Common Equity		 1,567 1,600 1,615 1,687 1,743 1,819 1,979
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,567 1,600 1,615 1,687 1,743 1,819 1,979
Common Stock		 1,790 1,807 1,850 1,882 1,912 1,933 1,966
Retained Earnings		 -246 -226 -234 -193 -164 -109 14
Accumulated Other Comprehensive Income / (Loss)		 23 19 -0.71 -1.87 -4.33 -6.29 -1.27
Noncontrolling Interest		 0.52 0.38 0.20 -0.13 -0.28 0.09 0.06

Annual Metrics And Ratios for BrightSpring Health Services

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 14.32% 27.65% 28.18%
EBITDA Growth		 0.00% -10.14% 14.18% 45.06%
EBIT Growth		 0.00% -21.64% 40.22% 173.50%
NOPAT Growth		 0.00% -21.64% 40.22% 196.83%
Net Income Growth		 0.00% -189.26% 86.92% 1,021.56%
EPS Growth		 0.00% -184.78% 93.13% 1,066.67%
Operating Cash Flow Growth		 0.00% 4,630.05% -88.72% 1,961.79%
Free Cash Flow Firm Growth		 0.00% 0.00% 102.61% -69.59%
Invested Capital Growth		 0.00% 0.00% 0.91% 1.53%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% -2.94%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -11.47%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -13.44%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -15.74%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 48.68%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 35.94%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 40.36%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -84.16%
Invested Capital Q/Q Growth		 0.00% 0.00% -5.28% 2.71%
Profitability Metrics		 - - - -
Gross Margin		 17.54% 16.24% 14.10% 11.76%
EBITDA Margin		 5.34% 4.20% 3.75% 3.65%
Operating Margin		 2.43% 1.67% 1.83% 2.29%
EBIT Margin		 2.43% 1.67% 1.83% 2.29%
Profit (Net Income) Margin		 -0.70% -1.78% -0.18% 1.46%
Tax Burden Percent		 118.50% 88.40% 59.07% 137.10%
Interest Burden Percent		 -24.36% -120.54% -16.83% 46.72%
Effective Tax Rate		 0.00% 0.00% 0.00% 24.03%
Return on Invested Capital (ROIC)		 0.00% 4.92% 3.43% 6.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -9.62% -1.93% 4.21%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -56.13% -5.25% 4.69%
Return on Equity (ROE)		 0.00% -51.21% -1.81% 10.69%
Cash Return on Invested Capital (CROIC)		 0.00% -195.08% 2.53% 4.48%
Operating Return on Assets (OROA)		 0.00% 2.66% 3.60% 4.79%
Return on Assets (ROA)		 0.00% -2.83% -0.36% 3.07%
Return on Common Equity (ROCE)		 0.00% -48.88% -1.79% 10.65%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -26.82% -1.25% 0.00%
Net Operating Profit after Tax (NOPAT)		 131 103 144 224
NOPAT Margin		 1.70% 1.17% 1.28% 1.74%
Net Nonoperating Expense Percent (NNEP)		 0.00% 14.54% 5.37% 1.78%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.47% 3.37% 4.95%
Cost of Revenue to Revenue		 82.46% 83.76% 85.90% 88.24%
SG&A Expenses to Revenue		 14.58% 14.58% 12.27% 9.47%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 15.11% 14.58% 12.27% 9.47%
Earnings before Interest and Taxes (EBIT)		 188 147 206 295
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 412 370 423 471
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 1.19 1.80 3.60
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.09 0.08 0.26 0.52
Price to Earnings (P/E)		 0.00 0.00 0.00 35.42
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 2.82%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.03 1.31 2.48
Enterprise Value to Revenue (EV/Rev)		 0.00 0.49 0.49 0.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 11.60 13.11 19.83
Enterprise Value to EBIT (EV/EBIT)		 0.00 29.19 26.86 31.62
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 41.70 38.37 41.62
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 20.38 233.17 19.04
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 52.08 55.71
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 5.86 1.60 1.41
Long-Term Debt to Equity		 0.00 5.81 1.57 1.38
Financial Leverage		 0.00 5.84 2.72 1.11
Leverage Ratio		 0.00 9.03 5.06 3.49
Compound Leverage Factor		 0.00 -10.89 -0.85 1.63
Debt to Total Capital		 0.00% 85.42% 61.48% 58.49%
Short-Term Debt to Total Capital		 0.00% 0.77% 1.14% 1.15%
Long-Term Debt to Total Capital		 0.00% 84.65% 60.34% 57.33%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.66% 0.09% 0.25%
Common Equity to Total Capital		 0.00% 13.92% 38.44% 41.27%
Debt to EBITDA		 0.00 9.69 6.23 5.65
Net Debt to EBITDA		 0.00 9.65 6.09 5.46
Long-Term Debt to EBITDA		 0.00 9.60 6.12 5.53
Debt to NOPAT		 0.00 34.83 18.24 11.85
Net Debt to NOPAT		 0.00 34.70 17.82 11.45
Long-Term Debt to NOPAT		 0.00 34.52 17.91 11.61
Altman Z-Score		 0.00 1.76 2.47 3.24
Noncontrolling Interest Sharing Ratio		 0.00% 4.54% 1.39% 0.42%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 1.17 1.33 1.57
Quick Ratio		 0.00 0.72 0.76 0.58
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -4,085 106 168
Operating Cash Flow to CapEx		 -6.64% 286.67% 29.38% 513.35%
Free Cash Flow to Firm to Interest Expense		 0.00 -12.58 0.44 1.07
Operating Cash Flow to Interest Expense		 -0.02 0.65 0.10 3.12
Operating Cash Flow Less CapEx to Interest Expense		 -0.32 0.42 -0.24 2.51
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 1.60 1.97 2.09
Accounts Receivable Turnover		 0.00 10.01 11.80 13.64
Inventory Turnover		 0.00 18.35 18.55 15.70
Fixed Asset Turnover		 0.00 35.89 45.41 67.02
Accounts Payable Turnover		 0.00 11.52 12.23 10.64
Days Sales Outstanding (DSO)		 0.00 36.46 30.94 26.75
Days Inventory Outstanding (DIO)		 0.00 19.89 19.67 23.26
Days Payable Outstanding (DPO)		 0.00 31.68 29.85 34.31
Cash Conversion Cycle (CCC)		 0.00 24.67 20.77 15.70
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 4,188 4,226 3,769
Invested Capital Turnover		 0.00 4.22 2.68 3.45
Increase / (Decrease) in Invested Capital		 0.00 4,188 38 57
Enterprise Value (EV)		 0.00 4,296 5,543 9,335
Market Capitalization		 693 693 2,965 6,754
Book Value per Share		 $0.00 $4.96 $9.46 $10.40
Tangible Book Value per Share		 $0.00 ($24.65) ($10.54) ($6.81)
Total Capital		 0.00 4,201 4,287 4,544
Total Debt		 0.00 3,588 2,636 2,658
Total Long-Term Debt		 0.00 3,556 2,587 2,605
Net Debt		 0.00 3,575 2,574 2,569
Capital Expenditures (CapEx)		 70 74 81 95
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 227 452 1,009
Debt-free Net Working Capital (DFNWC)		 0.00 240 513 1,097
Net Working Capital (NWC)		 0.00 208 465 1,045
Net Nonoperating Expense (NNE)		 186 260 165 35
Net Nonoperating Obligations (NNO)		 0.00 3,575 2,574 1,883
Total Depreciation and Amortization (D&A)		 224 223 217 176
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 2.58% 4.01% 7.82%
Debt-free Net Working Capital to Revenue		 0.00% 2.72% 4.56% 8.50%
Net Working Capital to Revenue		 0.00% 2.36% 4.12% 8.09%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.09) $0.94
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 193.00M 202.56M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.09) $0.87
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 193.00M 219.77M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 174.97M 193.54M
Normalized Net Operating Profit after Tax (NOPAT)		 160 103 144 224
Normalized NOPAT Margin		 2.07% 1.17% 1.28% 1.74%
Pre Tax Income Margin		 -0.59% -2.01% -0.31% 1.07%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.80 0.45 0.86 1.88
NOPAT to Interest Expense		 0.56 0.32 0.60 1.43
EBIT Less CapEx to Interest Expense		 0.50 0.23 0.52 1.27
NOPAT Less CapEx to Interest Expense		 0.26 0.09 0.26 0.82
Payout Ratios		 - - - -
Dividend Payout Ratio		 -1.38% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -1.38% -0.41% -14.45% 25.53%

Quarterly Metrics And Ratios for BrightSpring Health Services

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 193,536,850.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 193,536,850.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.77
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 27.03% 26.01% 28.82% 28.56% 25.92% 29.10% 28.17% 29.26% 25.56%
EBITDA Growth		 0.00% 0.00% -42.64% -14.92% 2,870.24% 9.69% 151.48% 2.17% 59.81% 33.12% 70.79%
EBIT Growth		 0.00% 0.00% -84.35% -21.61% 208.78% 15.81% 430.87% 25.62% 201.90% 94.66% 139.36%
NOPAT Growth		 0.00% 0.00% -84.35% 118.27% -1,691.56% 5.36% 585.31% 56.74% 225.91% 203.00% 109.06%
Net Income Growth		 0.00% 0.00% -108.23% 602.86% 93.10% 313.91% 162.54% 41.67% 715.09% 401.95% 412.27%
EPS Growth		 0.00% 0.00% -44.44% 233.33% 96.40% 320.00% 153.85% 30.00% 750.00% 209.09% 378.57%
Operating Cash Flow Growth		 0.00% 0.00% -297.66% 39.59% -19.13% -44.20% 228.84% 422.34% 296.15% 155.55% 21.01%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 111.75% 117.48% 119.32% -95.96% -93.08%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.91% -10.51% -16.41% -17.74% 1.53% 2.05%
Revenue Q/Q Growth		 4.14% 5.23% 0.00% 5.96% 6.47% 5.02% -5.72% 9.37% 5.92% 6.49% 1.78%
EBITDA Q/Q Growth		 -97.26% 3,262.11% 0.00% 87.15% -4.34% 24.16% -29.96% -2.57% 41.04% 14.50% 8.55%
EBIT Q/Q Growth		 -165.63% 230.64% 0.00% 673.70% -8.93% 39.08% -35.82% -4.30% 80.91% 23.08% 12.34%
NOPAT Q/Q Growth		 -165.63% 230.64% 0.00% 2,054.16% -638.71% 107.68% 3.47% -18.59% 56.52% 15.99% 41.45%
Net Income Q/Q Growth		 -4,804.41% 94.47% 0.00% 141.91% -146.20% 271.52% 88.33% -5.06% 100.57% 39.97% 92.20%
EPS Q/Q Growth		 -3,800.00% 95.50% 0.00% 138.46% -140.00% 375.00% 27.27% -7.14% 100.00% 30.77% 97.06%
Operating Cash Flow Q/Q Growth		 233.67% 382.03% 0.00% 80.69% 278.96% 232.57% 12.12% -51.70% 119.94% 114.53% -46.91%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -4.69% -19.24% 100.24% 3,824.87% 58.61% 11.91% -97.64% 65.28%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 7.51% 1.10% -5.28% -13.08% 0.42% -0.51% 2.71% -0.55%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 15.88% 15.53% 14.34% 14.25% 14.04% 13.82% 11.76% 11.91% 11.76% 11.62% 13.34%
EBITDA Margin		 0.16% 5.24% 2.38% 4.21% 3.78% 4.47% 3.32% 2.96% 3.94% 4.24% 4.52%
Operating Margin		 -2.32% 2.87% 0.31% 2.29% 1.96% 2.59% 1.76% 1.54% 2.63% 3.04% 3.36%
EBIT Margin		 -2.32% 2.87% 0.31% 2.29% 1.96% 2.59% 1.76% 1.54% 2.63% 3.04% 3.36%
Profit (Net Income) Margin		 -5.77% -0.30% -1.80% 0.71% -0.31% 0.50% 1.01% 0.88% 1.66% 2.18% 4.11%
Tax Burden Percent		 95.73% 48.68% 66.57% 194.90% -1,152.89% 63.69% 323.20% 281.64% 111.36% 111.13% 179.41%
Interest Burden Percent		 260.14% -21.67% -863.75% 15.98% 1.37% 30.60% 17.69% 20.14% 56.47% 64.36% 68.20%
Effective Tax Rate		 0.00% 0.00% 0.00% -94.90% 1,252.89% 36.31% -2.67% 12.66% 24.43% 28.78% 10.32%
Return on Invested Capital (ROIC)		 0.00% 4.24% 0.00% 0.00% 0.00% 4.42% 5.52% 4.18% 6.51% 7.48% 11.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 2.70% 0.00% 0.00% 0.00% 3.28% 4.50% 3.55% 6.04% 7.50% 13.20%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 15.78% 0.00% 0.00% 0.00% 8.91% 6.22% 5.04% 8.23% 8.36% 13.42%
Return on Equity (ROE)		 0.00% 20.02% 0.00% 0.00% 0.00% 13.33% 11.74% 9.22% 14.75% 15.84% 24.51%
Cash Return on Invested Capital (CROIC)		 0.00% -97.54% 0.00% 0.00% 0.00% 2.53% 16.61% 22.27% 26.02% 4.48% 5.88%
Operating Return on Assets (OROA)		 0.00% 4.59% 0.00% 0.00% 0.00% 5.09% 3.64% 3.36% 5.92% 6.37% 7.61%
Return on Assets (ROA)		 0.00% -0.48% 0.00% 0.00% 0.00% 0.99% 2.08% 1.90% 3.72% 4.56% 9.31%
Return on Common Equity (ROCE)		 0.00% 19.11% 0.00% 0.00% 0.00% 13.14% 11.70% 9.19% 14.72% 15.78% 24.41%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.25% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -37 48 5.65 122 -655 50 52 42 66 77 109
NOPAT Margin		 -1.62% 2.01% 0.22% 4.46% -22.54% 1.65% 1.81% 1.35% 1.99% 2.17% 3.01%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.54% 4.11% 7.28% -45.48% 1.14% 1.02% 0.63% 0.48% -0.02% -2.12%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.14% - - - 1.18% 1.19% 0.96% 1.48% 1.70% 2.35%
Cost of Revenue to Revenue		 84.12% 84.47% 85.66% 85.75% 85.96% 86.18% 88.24% 88.09% 88.24% 88.38% 86.66%
SG&A Expenses to Revenue		 18.19% 12.65% 14.02% 11.96% 12.08% 11.23% 9.99% 10.37% 9.12% 8.57% 9.98%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 18.19% 12.65% 14.02% 11.96% 12.08% 11.23% 9.99% 10.37% 9.12% 8.57% 9.98%
Earnings before Interest and Taxes (EBIT)		 -52 68 8.07 62 57 79 51 49 88 108 121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.70 124 61 115 110 137 96 93 131 150 163
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 1.19 0.37 1.22 1.56 1.80 1.88 2.36 2.88 3.60 4.17
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.08 0.00 0.00 0.00 0.26 0.27 0.33 0.39 0.52 0.60
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 55.31 62.74 40.41 35.42 26.61
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.81% 1.59% 2.47% 2.82% 3.76%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.03 0.76 1.08 1.20 1.31 1.58 1.82 2.11 2.48 2.67
Enterprise Value to Revenue (EV/Rev)		 0.00 0.49 0.00 0.00 0.00 0.49 0.49 0.53 0.58 0.72 0.73
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 11.60 0.00 0.00 0.00 13.11 12.05 13.91 14.58 19.83 18.60
Enterprise Value to EBIT (EV/EBIT)		 0.00 29.19 0.00 0.00 0.00 26.86 21.26 23.77 22.74 31.62 27.37
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 41.70 0.00 0.00 0.00 38.37 26.98 37.79 29.13 41.62 34.13
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 20.38 0.00 0.00 0.00 233.17 28.36 25.00 22.21 19.04 19.58
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 52.08 8.97 7.44 7.33 55.71 45.94
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 5.86 1.64 1.76 1.78 1.60 1.58 1.53 1.46 1.41 1.33
Long-Term Debt to Equity		 0.00 5.81 1.61 1.73 1.75 1.57 1.55 1.50 1.43 1.38 1.30
Financial Leverage		 0.00 5.84 1.61 1.75 1.76 2.72 1.38 1.42 1.36 1.11 1.02
Leverage Ratio		 0.00 9.03 3.59 3.49 3.57 5.06 3.52 3.45 3.44 3.49 3.28
Compound Leverage Factor		 0.00 -1.96 -31.03 0.56 0.05 1.55 0.62 0.69 1.94 2.24 2.24
Debt to Total Capital		 0.00% 85.42% 62.18% 63.81% 64.00% 61.48% 61.27% 60.47% 59.33% 58.49% 57.09%
Short-Term Debt to Total Capital		 0.00% 0.77% 1.17% 1.10% 1.09% 1.14% 1.12% 1.15% 1.16% 1.15% 1.14%
Long-Term Debt to Total Capital		 0.00% 84.65% 61.01% 62.72% 62.91% 60.34% 60.16% 59.31% 58.17% 57.33% 55.95%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.66% 0.16% 0.14% 0.10% 0.09% 0.07% 0.06% 0.05% 0.25% 0.23%
Common Equity to Total Capital		 0.00% 13.92% 37.66% 36.04% 35.90% 38.44% 38.65% 39.48% 40.62% 41.27% 42.68%
Debt to EBITDA		 0.00 9.69 0.00 0.00 0.00 6.23 5.57 5.53 5.00 5.65 4.92
Net Debt to EBITDA		 0.00 9.65 0.00 0.00 0.00 6.09 5.46 5.39 4.73 5.46 3.27
Long-Term Debt to EBITDA		 0.00 9.60 0.00 0.00 0.00 6.12 5.46 5.43 4.90 5.53 4.82
Debt to NOPAT		 0.00 34.83 0.00 0.00 0.00 18.24 12.46 15.03 9.98 11.85 9.02
Net Debt to NOPAT		 0.00 34.70 0.00 0.00 0.00 17.82 12.22 14.63 9.45 11.45 5.99
Long-Term Debt to NOPAT		 0.00 34.52 0.00 0.00 0.00 17.91 12.24 14.74 9.78 11.61 8.84
Altman Z-Score		 0.00 1.72 0.10 0.35 0.43 2.40 2.69 2.92 3.21 3.14 3.66
Noncontrolling Interest Sharing Ratio		 0.00% 4.54% 0.43% 0.39% 0.27% 1.39% 0.31% 0.26% 0.20% 0.42% 0.37%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.17 1.26 1.33 1.35 1.33 1.73 1.76 1.79 1.57 1.74
Quick Ratio		 0.00 0.72 0.84 0.88 0.84 0.76 0.71 0.69 0.74 0.58 1.29
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -4,099 -4,291 -5,117 12 483 767 858 20 33
Operating Cash Flow to CapEx		 188.23% 964.71% -361.47% -64.12% 135.94% 591.81% 576.21% 200.93% 684.79% 614.79% 570.66%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -52.72 -81.83 -91.27 0.22 11.57 19.77 22.44 0.53 0.87
Operating Cash Flow to Interest Expense		 0.40 1.96 -1.01 -0.29 0.49 1.65 2.43 1.27 2.82 6.01 3.18
Operating Cash Flow Less CapEx to Interest Expense		 0.19 1.75 -1.29 -0.74 0.13 1.37 2.01 0.64 2.41 5.03 2.63
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 1.60 0.00 0.00 0.00 1.97 2.06 2.18 2.25 2.09 2.26
Accounts Receivable Turnover		 0.00 10.01 0.00 0.00 0.00 11.80 12.06 12.84 13.05 13.64 13.07
Inventory Turnover		 0.00 18.35 0.00 0.00 0.00 18.55 22.54 21.75 20.64 15.70 21.91
Fixed Asset Turnover		 0.00 35.89 0.00 0.00 0.00 45.41 56.08 59.40 62.74 67.02 71.99
Accounts Payable Turnover		 0.00 11.52 0.00 0.00 0.00 12.23 13.42 13.30 13.27 10.64 12.23
Days Sales Outstanding (DSO)		 0.00 36.46 0.00 0.00 0.00 30.94 30.25 28.42 27.97 26.75 27.94
Days Inventory Outstanding (DIO)		 0.00 19.89 0.00 0.00 0.00 19.67 16.20 16.78 17.68 23.26 16.66
Days Payable Outstanding (DPO)		 0.00 31.68 0.00 0.00 0.00 29.85 27.20 27.44 27.50 34.31 29.84
Cash Conversion Cycle (CCC)		 0.00 24.67 0.00 0.00 0.00 20.77 19.25 17.76 18.15 15.70 14.75
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 4,188 4,104 4,413 4,461 4,226 3,673 3,688 3,670 3,769 3,749
Invested Capital Turnover		 0.00 2.11 0.00 0.00 0.00 2.68 3.05 3.10 3.27 3.45 3.68
Increase / (Decrease) in Invested Capital		 0.00 0.00 4,104 4,413 4,461 38 -431 -724 -792 57 75
Enterprise Value (EV)		 0.00 4,296 3,117 4,759 5,364 5,543 5,791 6,712 7,755 9,335 10,016
Market Capitalization		 693 693 580 1,946 2,517 2,965 3,165 4,110 5,237 6,754 8,247
Book Value per Share		 $0.00 $4.96 $8.93 $9.34 $9.42 $9.46 $9.64 $10.00 $10.27 $10.40 $10.23
Tangible Book Value per Share		 $0.00 ($24.65) ($10.81) ($10.96) ($11.08) ($10.54) ($7.15) ($6.72) ($6.06) ($6.81) ($5.64)
Total Capital		 0.00 4,201 4,163 4,438 4,497 4,287 4,365 4,415 4,477 4,544 4,637
Total Debt		 0.00 3,588 2,588 2,832 2,878 2,636 2,675 2,670 2,656 2,658 2,648
Total Long-Term Debt		 0.00 3,556 2,540 2,783 2,829 2,587 2,626 2,619 2,605 2,605 2,595
Net Debt		 0.00 3,575 2,530 2,807 2,842 2,574 2,623 2,599 2,516 2,569 1,759
Capital Expenditures (CapEx)		 18 17 22 24 20 15 18 24 16 38 22
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 227 318 400 459 452 1,067 1,123 1,142 1,009 305
Debt-free Net Working Capital (DFNWC)		 0.00 240 376 426 495 513 1,120 1,193 1,282 1,097 1,194
Net Working Capital (NWC)		 0.00 208 328 377 446 465 1,071 1,143 1,230 1,045 1,141
Net Nonoperating Expense (NNE)		 94 55 52 102 -646 35 23 15 11 -0.33 -40
Net Nonoperating Obligations (NNO)		 0.00 3,575 2,530 2,807 2,842 2,574 1,983 1,943 1,849 1,883 1,759
Total Depreciation and Amortization (D&A)		 56 56 53 53 53 58 45 45 44 42 42
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 2.58% 0.00% 0.00% 0.00% 4.01% 9.00% 8.94% 8.58% 7.82% 2.24%
Debt-free Net Working Capital to Revenue		 0.00% 2.72% 0.00% 0.00% 0.00% 4.56% 9.44% 9.50% 9.64% 8.50% 8.75%
Net Working Capital to Revenue		 0.00% 2.36% 0.00% 0.00% 0.00% 4.12% 9.03% 9.09% 9.25% 8.09% 8.36%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.05) ($0.26) $0.10 ($0.04) $0.11 $0.15 $0.14 $0.27 $0.38 $0.73
Adjusted Weighted Average Basic Shares Outstanding		 0.00 117.87M 175.53M 197.52M 198.49M 193.00M 201.01M 201.81M 203.49M 202.56M 204.71M
Adjusted Diluted Earnings per Share		 $0.00 ($0.05) ($0.26) $0.10 ($0.04) $0.11 $0.14 $0.13 $0.26 $0.34 $0.67
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 117.87M 175.53M 208.99M 198.49M 193.00M 214.93M 216.34M 217.98M 219.77M 221.32M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 171.32M 171.46M 174.13M 174.97M 174.25M 177.15M 180.35M 193.54M 193.92M
Normalized Net Operating Profit after Tax (NOPAT)		 -37 48 5.65 44 40 50 36 42 66 77 109
Normalized NOPAT Margin		 -1.62% 2.01% 0.22% 1.60% 1.37% 1.65% 1.23% 1.35% 1.99% 2.17% 3.01%
Pre Tax Income Margin		 -6.02% -0.62% -2.70% 0.37% 0.03% 0.79% 0.31% 0.31% 1.49% 1.96% 2.29%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -0.62 0.82 0.10 1.19 1.01 1.44 1.21 1.25 2.30 2.81 3.15
NOPAT to Interest Expense		 -0.44 0.58 0.07 2.32 -11.69 0.92 1.25 1.09 1.74 2.00 2.82
EBIT Less CapEx to Interest Expense		 -0.84 0.62 -0.18 0.74 0.66 1.16 0.79 0.62 1.89 1.83 2.59
NOPAT Less CapEx to Interest Expense		 -0.65 0.37 -0.21 1.87 -12.05 0.64 0.83 0.46 1.32 1.02 2.26
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.41% 0.00% 0.00% 0.00% -14.45% 13.56% 11.30% 4.01% 25.53% 33.42%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, four-year view of BrightSpring Health Services (BTSG) based on quarterly statements. Key takeaways: the top line has trended up, profitability has improved notably in the latest quarter, and cash generation is strong, but margins have compressed and the company carries a meaningful debt load with ongoing investing and financing cash outflows.

  • Revenue has trended higher across the four-year window, with Q4 2025 revenue of about $3.56B versus roughly $2.37B in Q4 2023, signaling sustained top-line growth.
  • Net income attributable to common shareholders rose to about $77.1M in Q4 2025, and basic/diluted EPS improved to $0.38 / $0.34, marking a strong bottom-line improvement versus prior periods.
  • Net cash from operating activities in Q4 2025 was about $231.6M, up from $90.6M in Q4 2024, indicating stronger cash generation.
  • Operating income was about $108.1M in Q4 2025, turning positive after prior quarters and supporting profitability momentum.
  • Liquidity looks solid: as of 2025 Q3, total current assets were around $2.78B and total current liabilities about $1.55B, yielding a current ratio near 1.8x; cash on hand was roughly $140M.
  • Gross margin has compressed, with Q4 2025 gross margin around 11.6% (about $412.5M gross profit on $3.56B revenue), lower than levels seen in several earlier years.
  • The company carries a sizable leverage load, with long-term debt around $2.47B and total liabilities about $4.23B as of 2025 Q3.
  • Investing activities remain a meaningful cash outflow, with net cash from continuing investing activities about $233.9M used in Q4 2025.
  • Financing activities produced negative cash flow in several periods, driven by debt repayments and equity actions (net financing cash flow around -$50.5M in Q4 2025).
  • Discontinued operations contribute to quarterly net income swings, which can affect comparability across periods.
05/16/26 05:46 PM ETAI Generated. May Contain Errors.

BrightSpring Health Services Financials - Frequently Asked Questions

According to the most recent income statement we have on file, BrightSpring Health Services' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

BrightSpring Health Services' net income appears to be on a downward trend, with a most recent value of $189.11 million in 2025, falling from -$54.22 million in 2022. The previous period was -$20.52 million in 2024. Find out what analysts predict for BrightSpring Health Services in the coming months.

BrightSpring Health Services' total operating income in 2025 was $295.25 million, based on the following breakdown:
  • Total Gross Profit: $1.52 billion
  • Total Operating Expenses: $1.22 billion

Over the last 3 years, BrightSpring Health Services' total revenue changed from $7.72 billion in 2022 to $12.91 billion in 2025, a change of 67.2%.

BrightSpring Health Services' total liabilities were at $4.53 billion at the end of 2025, a 5.9% increase from 2024, and a 8.0% decrease since 2023.

In the past 2 years, BrightSpring Health Services' cash and equivalents has ranged from $13.07 million in 2023 to $88.37 million in 2025, and is currently $88.37 million as of their latest financial filing in 2025.

Over the last 3 years, BrightSpring Health Services' book value per share changed from 0.00 in 2022 to 10.40 in 2025, a change of 1,039.7%.


Related Companies

Financial statements for NASDAQ:BTSGU last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Trading legend: “I made millions for CEO clients just repeating this 1 secret”
TradeSmith Senior Analyst Jeff Clark has guided readers through 300-plus winning trades over 9 years - across ...
TradeSmith | Sponsoredtc pixel